Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period

Background: Limited data currently exist on the incidence of Clostridioides difficile infection (CDI) in Saudi Arabia. Compliance with CDI treatment guidelines is prudent for proper management of the infection and preventing recurrence. Methods: This was an epidemiologic and retrospective cohort stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Nouf A. Aljafel (Author), Hadeel H. Al-Shaikhy (Author), Maram A. Alnahdi (Author), Abrar K. Thabit (Author)
Format: Book
Published: Elsevier, 2020-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c57cb885b7d74b56a4c8a791c01f16c0
042 |a dc 
100 1 0 |a Nouf A. Aljafel  |e author 
700 1 0 |a Hadeel H. Al-Shaikhy  |e author 
700 1 0 |a Maram A. Alnahdi  |e author 
700 1 0 |a Abrar K. Thabit  |e author 
245 0 0 |a Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period 
260 |b Elsevier,   |c 2020-08-01T00:00:00Z. 
500 |a 1876-0341 
500 |a 10.1016/j.jiph.2020.03.007 
520 |a Background: Limited data currently exist on the incidence of Clostridioides difficile infection (CDI) in Saudi Arabia. Compliance with CDI treatment guidelines is prudent for proper management of the infection and preventing recurrence. Methods: This was an epidemiologic and retrospective cohort study to find the 10-year cumulative incidence of CDI (December 2007-January 2018) among patients presented with diarrhea or experienced diarrhea during hospitalization and the correlation between clinical outcomes and the compliance of treatment regimens with pertinent global guidelines (IDSA/SHEA, ACG, and ESCMID guidelines). Results: At our institution, the 10-year CDI cumulative incidence was 8.4%. A total of 170 patients were included in the analysis of compliance with the guidelines and clinical outcomes. Most patients had non-severe CDI according to all three guidelines. Clinical cure was found in 76.5% of the cases although all-cause mortality rate was 28.2%. Median (IQR) hospitalization period was 11 (5-29) days. Compliance with all three guidelines was significantly associated with clinical cure (R = 0.24-0.27; P ≤ 0.002). Lower mortality also significantly correlated with compliance with IDSA and ACG guidelines (P ≤ 0.03), but not with ESCMID guidelines (P = 0.05). While compliance with all three guidelines was associated with lower risk of recurrence, this finding was not statistically significant. Conclusion: CDI rates reported in this study were very low reflecting a low incidence at our institution. As guidelines were prepared by a panel of experts using most reliable evidence, results shown in this study indicate the importance of following guidelines recommendations for better patient outcomes. 
546 |a EN 
690 |a Clostridioides difficile 
690 |a Clostridium difficile 
690 |a Compliance 
690 |a Guidelines 
690 |a Saudi Arabia 
690 |a Infectious and parasitic diseases 
690 |a RC109-216 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Journal of Infection and Public Health, Vol 13, Iss 8, Pp 1156-1160 (2020) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1876034120304081 
787 0 |n https://doaj.org/toc/1876-0341 
856 4 1 |u https://doaj.org/article/c57cb885b7d74b56a4c8a791c01f16c0  |z Connect to this object online.